Security key
483497103
KalVista Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (KALV)
CUSIP: 483497103
Q3 2018 13F Holders as of 30 Sep 2018
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Total 13F shares
- 12,319,459
- Total 13F value
- $272,385,000
- Share change
- +5,040,506
- SEC-reported price per share
- $22.11
- Number of holders
- 46
- Value change
- +$112,676,598
- Number of buys
- 32
- Number of sells
- 10
- Shares outstanding
- 53,230,928
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2018
Institutions
46
Top holders
10
KALV full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2018
Previous quarter: Q2 2018
KalVista Pharmaceuticals, Inc. SEC filings
KalVista Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 483497103
Recent filing periods:
Ownership snapshot
Top reported holders of KALV - KalVista Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
SV Health Investors, LLC
Disclosed value leader
SV Health Investors, LLC
Comparable rows
15/15
Latest evidence
30 Jun 2018
13F
Lead comparable stake: 4.8%
Showing 1-6 of 15 holder rows.
Quick read
SV Health Investors, LLC leads the comparable SEC ownership view at 4.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens SV Health Investors, LLC's linked filing trail.
Comparable ownership
Top 5
SV Health Investors, LLC
4.8%
RA CAPITAL MANAGEMENT, L.P.
2.7%
EVENTIDE ASSET MANAGEMENT, LLC
1.7%
INTERWEST VENTURE MANAGEMENT CO
0.62%
INTERNATIONAL BIOTECHNOLOGY TRUST...
0.61%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| SV Health Investors, LLC |
13F
Company
|
4.8%
|
$20,945,000
2,579,490 shares
|
— | 30 Jun 2018 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
2.7%
|
$11,701,000
1,441,070 shares
|
— | 30 Jun 2018 |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
Company
|
1.7%
|
$7,308,000
900,000 shares
|
— | 30 Jun 2018 |
| INTERWEST VENTURE MANAGEMENT CO |
13F
Company
|
0.62%
|
$2,679,000
329,942 shares
|
— | 30 Jun 2018 |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
Company
|
0.61%
|
$2,612,000
322,436 shares
|
— | 30 Jun 2018 |
| Vivo Capital, LLC |
13F
Company
|
0.56%
|
$2,439,000
300,325 shares
|
— | 30 Jun 2018 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2018
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
46
Shares
12,319,459
Rows available
46
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2018 vs Q2 2018 Across Filers
Q2 2018 holders
24
Q3 2018 holders
46
Holder diff
22
| Investor | Q2 2018 Shares | Q3 2018 Shares | Share Diff | Share Chg % | Q2 2018 value | Q3 2018 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend